Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
Curr Neuropharmacol. 2022 Nov 15;20(12):2248-2266. doi: 10.2174/1570159X20666220222144744.
Neonatal arterial ischaemic stroke (NAIS) is caused by focal arterial occlusion and often leads to severe neurological sequelae. Neural deaths after NAIS mainly include necrosis, apoptosis, necroptosis, autophagy, ferroptosis, and pyroptosis. These neural deaths are mainly caused by upstream stimulations, including excitotoxicity, oxidative stress, inflammation, and death receptor pathways. The current clinical approaches to managing NAIS mainly focus on supportive treatments, including seizure control and anticoagulation. In recent years, research on the pathology, early diagnosis, and potential therapeutic targets of NAIS has progressed. In this review, we summarise the latest progress of research on the pathology, diagnosis, treatment, and prognosis of NAIS and highlight newly potential diagnostic and treatment approaches.
新生儿动脉缺血性脑卒中(NAIS)由局灶性动脉闭塞引起,常导致严重的神经后遗症。NAIS 后的神经死亡主要包括坏死、凋亡、坏死性凋亡、自噬、铁死亡和细胞焦亡。这些神经死亡主要由兴奋性毒性、氧化应激、炎症和死亡受体途径等上游刺激引起。目前,NAIS 的临床治疗方法主要集中在支持性治疗上,包括控制癫痫发作和抗凝治疗。近年来,NAIS 的病理学、早期诊断和潜在治疗靶点的研究取得了进展。在这篇综述中,我们总结了 NAIS 的病理学、诊断、治疗和预后研究的最新进展,并强调了新的潜在诊断和治疗方法。